Home
Latest
E-paper
Companies
Industry
Economy
WebinarsNew
Deep DiveNew
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Premium
Indulgence
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Glenmark Pharmaceuticals said it has received approval from the US health regulator to market Nintedanib capsules, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer
The combo treatment has been approved in the United States for adult patients with extensive-stage small cell lung cancer, the company said
US FDA granted approval for expanded use of Imfinzi to treat non-small cell lung cancer patients
